Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Indication: Meningococcal Vaccination Age: High risk adults |
Dose: Injection – 0.5 mL/dose Frequency: single dose Note: Intramuscular. Indicated active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. |
|
Indication: Primary Meningococcal Vaccination Age: 2 through 55 years |
Dose: Injection – 0.5 mL Frequency: single dose Note: Intramuscular. |
| Clinical Information | Administration Information |
|---|---|
|
Indication: Primary Vaccination Age: 2 months |
Dose: Injection – 0.5 mL Frequency: 4-dose series administered at 2, 4, 6, and 12 months of age |
|
Indication: Primary Vaccination Age: 7 months through 23 months |
Dose: Injection – 0.5 mL Frequency: 2-dose series Note: second dose administered in the second year of life and at least 3 months after the first dose |
| Drug Name | Risk Factors |
|---|---|
|
Immunosuppressive therapies (e.g. irradiation, Antimetabolites (Methotrexate, Fluorouracil, Mercaptopurine)s, Alkylating Agents (Cyclophosphamide, Busulfan, Melphalan), cytotoxic drugs, Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone))
|
Reduced immune response
|
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Details coming soon
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.